88 related articles for article (PubMed ID: 2513287)
1. Treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Glazier JJ; Crowley J; Cremin D; Coll T; Daly K
Ir Med J; 1989 Sep; 82(3):111-4. PubMed ID: 2513287
[TBL] [Abstract][Full Text] [Related]
2. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
[TBL] [Abstract][Full Text] [Related]
3. [t-PA in thrombolytic therapy of acute myocardial infarct].
Rutsch W; Schmutzler H
Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
[TBL] [Abstract][Full Text] [Related]
4. Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.
Gurbel PA; Anderson RD; MacCord CS; Scott H; Serebruany V; Herzog WR
Coron Artery Dis; 1994 Nov; 5(11):929-36. PubMed ID: 7719525
[TBL] [Abstract][Full Text] [Related]
5. [New thrombolytic agents in myocardial infarction].
Charbonnier B; Lang M; Brochier M
Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator: a new thrombolytic agent.
Crabbe SJ; Cloninger CC
Clin Pharm; 1987 May; 6(5):373-86. PubMed ID: 3117481
[TBL] [Abstract][Full Text] [Related]
7. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
[TBL] [Abstract][Full Text] [Related]
8. Non neutralizing antibodies to tissue type plasminogen activator in the serum of acute myocardial infarction patients treated with the recombinant protein.
Cugno M; Cicardi M; Colucci M; Bisiani G; Merlini PA; Spinola A; Paonessa R; Agostoni A
Thromb Haemost; 1996 Aug; 76(2):234-8. PubMed ID: 8865537
[TBL] [Abstract][Full Text] [Related]
9. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
Kobusiak-Prokopowicz M; Mysiak A
Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
[TBL] [Abstract][Full Text] [Related]
10. [Platelet activation in the early phases of acute myocardial infarction].
Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G
Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of combination therapy of hybrid thrombolysis followed by back-up percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction].
Mukawa H; Sone T; Tsuboi H; Kondo J; Kosokabe T; Uesugi M; Imai H
J Cardiol; 2001 Apr; 37(4):181-9. PubMed ID: 11337927
[TBL] [Abstract][Full Text] [Related]
12. New developments in thrombolytic therapy.
Collen D; Gold HK
Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261
[TBL] [Abstract][Full Text] [Related]
13. [Intravenous thrombolysis by recombinant plasminogen activator (rt-PA) in unstable angina. A randomized multicenter study versus placebo].
Charbonnier B; Bernadet P; Schiele F; Thery C; Baudouy M; Bauters C
Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1471-7. PubMed ID: 1297297
[TBL] [Abstract][Full Text] [Related]
14. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
[TBL] [Abstract][Full Text] [Related]
15. Coronary thrombolysis with clot-selective plasminogen activators.
Collen D; Bounameaux H
Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
[TBL] [Abstract][Full Text] [Related]
16. Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group.
Morgan CD; Gent M; Daly PA; Baigrie RS; Haq A; Roberts RS; Armstrong PW
Can J Cardiol; 1994 Nov; 10(9):897-904. PubMed ID: 7954025
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
[TBL] [Abstract][Full Text] [Related]
18. Influence of cardiac output on peak t-PA plasma levels in patients receiving thrombolytic therapy with recombinant tissue-type plasminogen activator--correlation with patency rate.
Huber K; Beckmann R; Probst P; Rauscha F; Kaindl F; Binder BR
Thromb Haemost; 1993 Jan; 69(1):45-9. PubMed ID: 8446938
[TBL] [Abstract][Full Text] [Related]
19. Recombinant tissue-plasminogen activator (rt-PA) in acute myocardial infarction in the Chinese in Hong Kong.
Woo KS; Tse KK; Mak YK; Chung HK; Tse CY
Chin Med J (Engl); 1992 May; 105(5):374-8. PubMed ID: 1499366
[TBL] [Abstract][Full Text] [Related]
20. [Earlier treatment of acute myocardial infarction with administration of alteplase (rt-PA) before hospitalization].
Bouten MJ; Simoons ML; Hartman JA; van Miltenburg AJ; van der Does E; Pool J
Ned Tijdschr Geneeskd; 1990 Dec; 134(50):2434-8. PubMed ID: 2124655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]